These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28363357)

  • 1. Variation in Placebo Effect Sizes in Clinical Trials of Oral Interventions for Management of the Behavioral and Psychological Symptoms of Dementia (BPSD): A Systematic Review and Meta-Analysis.
    Hyde AJ; May BH; Xue CC; Zhang AL
    Am J Geriatr Psychiatry; 2017 Sep; 25(9):994-1008. PubMed ID: 28363357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
    Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
    JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials.
    Cheung G; Stapelberg J
    N Z Med J; 2011 Jun; 124(1336):39-50. PubMed ID: 21946743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
    Savaskan E; Mueller H; Hoerr R; von Gunten A; Gauthier S
    Int Psychogeriatr; 2018 Mar; 30(3):285-293. PubMed ID: 28931444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.
    Maidment ID; Fox CG; Boustani M; Rodriguez J; Brown RC; Katona CL
    Ann Pharmacother; 2008 Jan; 42(1):32-8. PubMed ID: 18056833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia.
    Hsu TJ; Tsai HT; Hwang AC; Chen LY; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():28-35. PubMed ID: 28436192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    Jin B; Liu H
    J Neurol; 2019 Oct; 266(10):2363-2375. PubMed ID: 30666436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsants for behavioral and psychological symptoms in dementia: protocol for a systematic review.
    Benjamin S; Williams JW; Cotton C; Tung J; An H; Sanger S; Ho JM
    Syst Rev; 2019 May; 8(1):118. PubMed ID: 31103045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials.
    Matsuda Y; Kishi T; Shibayama H; Iwata N
    Hum Psychopharmacol; 2013 Jan; 28(1):80-6. PubMed ID: 23359469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
    Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
    Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
    Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in Australia.
    Macfarlane S; Atee M; Morris T; Whiting D; Healy M; Alford M; Cunningham C
    Front Psychiatry; 2021; 12():652254. PubMed ID: 33927656
    [No Abstract]   [Full Text] [Related]  

  • 17. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
    CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.